136 related articles for article (PubMed ID: 11386016)
1. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs.
Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS
Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016
[TBL] [Abstract][Full Text] [Related]
2. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women.
Baranowska B; Wolińska-Witort E; Martyńska L; Chmielowska M; Baranowska-Bik A
Neuro Endocrinol Lett; 2005 Aug; 26(4):293-6. PubMed ID: 16135994
[TBL] [Abstract][Full Text] [Related]
3. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women.
Waluga M; Janusz M; Karpel E; Hartleb M; Nowak A
Clin Physiol; 1998 Jan; 18(1):69-76. PubMed ID: 9545623
[TBL] [Abstract][Full Text] [Related]
5. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
[TBL] [Abstract][Full Text] [Related]
6. [Leptin and neuropeptide Y serum levls in young obese during weight loss].
Moro D; Mazzilli G; Grugni G; Guzzaloni G; Tedeschi S; Morabito F
Minerva Endocrinol; 1998 Dec; 23(4):105-10. PubMed ID: 10361808
[TBL] [Abstract][Full Text] [Related]
7. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa.
Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Chmielowska M
Neuro Endocrinol Lett; 2001 Oct; 22(5):356-8. PubMed ID: 11600878
[TBL] [Abstract][Full Text] [Related]
8. [Blood leptin, orexins and NPY levels and their relations in obese children].
Lou XM; Duan GC; Chen J; Zhou Y; Hu QY; Heng ZC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):621-4. PubMed ID: 16909617
[TBL] [Abstract][Full Text] [Related]
9. Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model.
Looije NA; Risovic V; Stewart DJ; Debeyer D; Kutney J; Wasan KM
J Pharm Pharm Sci; 2005 Aug; 8(3):400-8. PubMed ID: 16401390
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance.
Hioki C; Yoshimoto K; Yoshida T
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):614-9. PubMed ID: 15479169
[TBL] [Abstract][Full Text] [Related]
11. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
Preuss HG; DiFerdinando D; Bagchi M; Bagchi D
J Med; 2002; 33(1-4):247-64. PubMed ID: 12939122
[TBL] [Abstract][Full Text] [Related]
12. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
Gadde KM; Yonish GM; Wagner HR; Foust MS; Allison DB
Int J Obes (Lond); 2006 Jul; 30(7):1138-42. PubMed ID: 16418753
[TBL] [Abstract][Full Text] [Related]
13. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
14. Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise.
Madsen BK; Husum D; Videbaek R; Stokholm KH; Saelsen L; Christensen NJ
Scand J Clin Lab Invest; 1993 Oct; 53(6):569-76. PubMed ID: 8266002
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W
Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676
[TBL] [Abstract][Full Text] [Related]
16. Effects of short-term hypocaloric diet on sympatho-vagal interaction assessed by spectral analysis of heart rate and blood pressure variability during stress tests in obese hypertensive patients.
Ashida T; Ono C; Sugiyama T
Hypertens Res; 2007 Dec; 30(12):1199-203. PubMed ID: 18344625
[TBL] [Abstract][Full Text] [Related]
17. Adrenergic control of lipolysis and metabolic responses in obesity.
Zahorska-Markiewicz B; Kucio C; Piskorska D
Horm Metab Res; 1986 Oct; 18(10):693-7. PubMed ID: 2877928
[TBL] [Abstract][Full Text] [Related]
18. The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders.
Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Martynska L; Chmielowska M
Neuro Endocrinol Lett; 2003 Dec; 24(6):431-4. PubMed ID: 15073570
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular changes after treatment with dexfenfluramine and yohimbine in obese women measured by thoracic electrical bioimpedance.
Waluga M; Janusz M; Karpel E; Hartleb M; Nowak A
Boll Chim Farm; 1999; 138(7):359-63. PubMed ID: 10597657
[TBL] [Abstract][Full Text] [Related]
20. [Changes of plasma level of neuropeptide Y in patients with pregnancy induced hypertension].
Jin L; Wang C
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):206-8. PubMed ID: 11783361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
